Інвазивне ведення пацієнтів з інфарктом міокарда, ускладненим кардіогенним шоком: наукова заява Американської асоціації серця

T.D. Henry, M.I. Tomey, J.E. Tamis-Holland, H. Thiele, S.V. Rao, V. Menon, D.G. Klein, Y. Naka, I.L. Piña, N.K. Kapur, G.D. Dangas, від імені Комітету з інтервенційної кардіологічної допомоги (Рада з клінічної кардіології Американської асоціації серця); Ради з атеросклерозу, тромбозу і судинної біології; Ради з медсестринства у сфері кардіології та інсульту

Література     

 

1.            Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, Parissis J, Banaszewski M, Silva-Cardoso J, Carubelli V, et al; CardShock Study Inves- tigators; GREAT Network. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17:501–509. doi: 10.1002/ejhf.260
2.            Kolte D, Khera S, Aronow WS, Mujib M, Palaniswamy C, Sule S, Jain D, Gotsis W, Ahmed A, Frishman WH, et al. Trends in incidence, manage- ment, and outcomes of cardiogenic shock complicating ST-elevation myo- cardial infarction in the United States. J Am Heart Assoc. 2014;3:e000590. doi: 10.1161/JAHA.113.000590
3.            Reynolds  HR,  Hochman  JS.  Cardiogenic   shock:   current   concepts and improving outcomes. Circulation. 2008;117:686–697. doi: 10.1161/CIRCULATIONAHA.106.613596
4.            van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, Kilic A, Menon V, Ohman EM, Sweitzer NK, et al; on behalf of the American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline. Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation. 2017;136:e232–e268.  doi:  10.1161/CIR.0000000000000525
5.            Thiele H, Ohman EM, de Waha-Thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. Eur Heart J. 2019;40:2671–2683. doi: 10.1093/eurheartj/ehz363
6.            Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock: SHOCK investigators: Should We Emergently Revascularize Occluded Coro- naries for Cardiogenic Shock. N Engl J Med. 1999;341:625–634. doi: 10.1056/NEJM199908263410901
7.            Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, et al; IABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarc- tion with cardiogenic shock. N Engl J Med. 2012;367:1287–1296. doi: 10.1056/NEJMoa1208410
8.           Baran DA, Grines CL, Bailey S, Burkhoff D, Hall SA, Henry TD, Hollenberg SM, Kapur NK, O’Neill W, Ornato JP, et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock: this document was endorsed by the American College of Cardiology (ACC), the American Heart Association (AHA), the Society of Critical Care Medicine (SCCM), and the Society of Thoracic Surgeons (STS) in April 2019. Catheter Cardio- vasc Interv. 2019;94:29–37. doi: 10.1002/ccd.28329
9.           Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, et al; CULPRIT-SHOCK Investigators. PCI strategies in patients with acute myocardial infarc- tion and cardiogenic shock. N Engl J Med. 2017;377:2419–2432. doi: 10.1056/NEJMoa1710261
10.          Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS; NRMI Investigators. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA. 2005;294:448–454.  doi:  10.1001/jama.294.4.448
11.          Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, et al. Temporal trends and outcomes of patients undergoing percutaneous coronary interventions for cardiogenic shock in the setting of acute myocardial infarction: a report from the CathPCI Registry. JACC Cardiovasc Interv. 2016;9:341–351. doi: 10.1016/j.jcin.2015.10.039
12.      Hunziker L, Radovanovic D, Jeger R,  Pedrazzini  G,  Cuculi  F,  Urban  P, Erne P, Rickli H, Pilgrim T. Twenty-year trends in the incidence and out- come of cardiogenic shock in AMIS plus registry. Circ Cardiovasc Interv. 2019;12:e007293.  doi:  10.1161/CIRCINTERVENTIONS.118.007293
13.          Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, Fang JC, Scirica BM, Henry TD, Granger CB. Post-hospital outcomes of patients with acute myocardial infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67:739–747. doi: 10.1016/j.jacc.2015.11.048
14.          Tehrani B, Truesdell A, Singh R, Murphy C, Saulino P. Implementation of a cardiogenic shock team and clinical outcomes (INOVA-SHOCK Registry): observational and retrospective study. JMIR Res Protoc. 2018;7:e160. doi: 10.2196/resprot.9761
15.          Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, Khandelwal A, Hanson I, George A, Ashbrook M, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardio- genic shock: the Detroit Cardiogenic Shock Initiative. Catheter Cardiovasc Interv.  2018;91:454–461. doi: 10.1002/ccd.27427
16.          Levy B, Clere-Jehl R, Legras A, Morichau-Beauchant T, Leone M, Frederique G, Quenot JP, Kimmoun A, Cariou A, Lassus J, et al. Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction. J Am  Coll  Cardiol.  2018;72:173–182. doi: 10.1016/j.jacc.2018.04.051
17.          De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL; SOAP II Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–789. doi: 10.1056/NEJMoa0907118
18.          Ouweneel DM, Eriksen E, Sjauw KD, van Dongen IM, Hirsch A, Packer EJ, Vis MM, Wykrzykowska JJ, Koch KT, Baan J, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:278–287. doi: 10.1016/j.jacc.2016.10.022
19.          Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA. Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol. 2019;74:2117–2128. doi: 10.1016/j.jacc.2019.07.077
20.       Schrage B, Dabboura S, Yan I, Hilal R, Neumann JT, Sörensen NA, Goßling A, Becher PM, Grahn H, Wagner T, et al. Application of the SCAI classifica- tion in a cohort of patients with cardiogenic shock. Catheter Cardiovasc Interv.  2020;96:E213–E219. doi: 10.1002/ccd.28707
21.          Kochar A, Al-Khalidi HR, Hansen SM, Shavadia JS, Roettig ML, Fordyce CB, Doerfler S, Gersh BJ, Henry TD, Berger PB, et al. Delays in primary percutaneous coronary intervention in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. JACC Cardiovasc Interv.  2018;11:1824–1833.  doi:  10.1016/j.jcin.2018.06.030
22.       Scholz KH, Maier SKG, Maier LS, Lengenfelder B, Jacobshagen C, Jung J, Fleischmann C, Werner GS, Olbrich HG, Ott R, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39:1065–1074.  doi:  10.1093/eurheartj/ehy004
23.       Vallabhajosyula S, Prasad A, Dunlay SM, Murphree DH Jr, Ingram C, Mueller PS, Gersh BJ, Holmes DR Jr, Barsness GW. Utilization of palliative care for cardiogenic shock complicating acute myocardial infarction: a 15- year national perspective on trends, disparities, predictors, and outcomes. J Am Heart Assoc. 2019;8:e011954. doi: 10.1161/JAHA.119.011954
24.       Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion follow- ing postcardiotomy shock: experience with the Abiomed BVS system. J Card Surg. 1999;14:288–293. doi: 10.1111/j.1540-8191.1999.tb00996.x
25.          Vallabhajosyula S, Kashani K, Dunlay SM, Vallabhajosyula S, Vallabhajosyula S, Sundaragiri PR, Gersh BJ, Jaffe AS, Barsness GW. Acute respiratory failure and mechanical ventilation in cardiogenic shock compli- cating acute myocardial infarction in the USA, 2000-2014. Ann Intensive Care. 2019;9:96. doi: 10.1186/s13613-019-0571-2
26.          Planer D, Mehran R, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Reyes SL, Stone GW. Prognostic utility of left ventric- ular end-diastolic pressure in patients with ST-segment elevation myocar- dial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2011;108:1068–1074. doi: 10.1016/j.amjcard.2011.06.007
27.          Kirtane AJ, Bui A, Murphy SA, Karmpaliotis D, Kosmidou I, Boundy K, Rahman A, Pinto DS, Aroesty JM, Giugliano RP, et al; TIMI Study Group. As- sociation of epicardial and tissue-level reperfusion with left ventricular end- diastolic pressures in ST-elevation myocardial infarction. J Thromb Throm- bolysis.  2004;17:177–184. doi: 10.1023/B:THRO.0000040486.10549.f6
28.          Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G; SHOCK Investigators. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial reg- istry. J Am Coll Cardiol. 2004;44:340–348. doi: 10.1016/j.jacc.2004.03.060
29.          Korabathina R, Heffernan KS, Paruchuri V, Patel AR, Mudd JO, Prutkin JM, Orr NM, Weintraub A, Kimmelstiel CD, Kapur NK. The pulmonary ar- tery pulsatility index identifies severe right ventricular dysfunction in acute inferior myocardial infarction. Catheter Cardiovasc Interv. 2012;80:593– 600. doi: 10.1002/ccd.23309
30.          Lala A, Guo Y, Xu J, Esposito M, Morine K, Karas R, Katz SD, Hochman JS, Burkhoff D, Kapur NK. Right ventricular dysfunction in acute myocardial infarction complicated by cardiogenic shock: a hemodynamic analysis of the Should We Emergently Revascularize Occluded Coronaries for Cardio- genic Shock (SHOCK) trial and registry. J Card Fail. 2018;24:148–156. doi: 10.1016/j.cardfail.2017.10.009
31.          Saxena A, Garan AR, Kapur NK, O’Neill WW, Lindenfeld J, Pinney SP, Uriel N, Burkhoff D, Kern M. Value of hemodynamic monitoring in patients with cardiogenic shock undergoing mechanical circulatory support. Circulation. 2020;141:1184–1197.   doi:   10.1161/CIRCULATIONAHA.119.043080
32.          Russo JJ, Aleksova N, Pitcher I, Couture E, Parlow S, Faraz M, Visintini S, Simard T, Di Santo P, Mathew R, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol. 2019;73:654–662. doi: 10.1016/j.jacc.2018.10.085
33.          Kapur NK, Davila CD, Chweich H. Protecting the vulnerable left ventricle: the art of unloading with VA-ECMO. Circ Heart Fail. 2019;12:e006581. doi:  10.1161/CIRCHEARTFAILURE.119.006581
34.          Kapur NK, Reyelt L, Swain L, Esposito M, Qiao  X,  Annamalai  S, Meyns B, Smalling R. Mechanical left ventricular  unloading  to  re- duce  infarct  size  during  acute  myocardial  infarction:  insight  from preclinical and clinical studies. J Cardiovasc Transl Res. 2019;12:87–94. doi: 10.1007/s12265-019-09876-3
35.          Chung SY, Tong MS, Sheu JJ, Lee FY, Sung PH, Chen CJ, Yang CH, Wu CJ, Yip HK. Short-term and long-term prognostic outcomes of patients with ST-segment elevation myocardial infarction complicated by profound cardiogenic shock undergoing early extracorporeal membrane oxygen- ator-assisted primary percutaneous coronary intervention. Int J Cardiol. 2016;223:412–417. doi: 10.1016/j.ijcard.2016.08.068
36.          Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, Hanson I, Almany S, Timmis S, Dixon S, et al; National Cardiogenic Shock Initiative Investigators. Improved outcomes associated with the use of shock pro- tocols: updates from the National Cardiogenic Shock Initiative. Catheter Cardiovasc Interv. 2019;93:1173–1183. doi: 10.1002/ccd.28307
37.          Seyfarth M, Sibbing D, Bauer I, Fröhlich G, Bott-Flügel L, Byrne R, Dirschinger J, Kastrati A, Schömig A. A randomized clinical trial to evaluate the safety and ef- fi of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol. 2008;52:1584–1588. doi: 10.1016/j.jacc.2008.05.065
38.          Cheng JM, den Uil CA, Hoeks SE, van der Ent M, Jewbali LS, van Domburg RT, Serruys PW. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009;30:2102–2108. doi: 10.1093/eurheartj/ehp292
39.          Helgestad OKL, Josiassen J, Hassager C, Jensen LO, Holmvang L, Udesen NLJ, Schmidt H, Berg Ravn H, Moller JE. Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock. Open Heart. 2020;7:e001214. doi: 10.1136/openhrt-2019-001214
40.          Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock. Circulation. 2019;139:1249–1258.   doi:   10.1161/CIRCULATIONAHA.118.036614
41.          Udesen NJ, Møller JE, Lindholm MG, Eiskjær H, Schäfer A, Werner N, Holmvang L, Terkelsen CJ, Jensen LO, Junker A, et al; DanGer Shock investi- gators. Rationale and design of DanGer shock: Danish-German Cardiogenic Shock trial. Am Heart J. 2019;214:60–68. doi: 10.1016/j.ahj.2019.04.019
42.          Amin AP, Spertus JA, Curtis JP, Desai N, Masoudi FA, Bach RG, McNeely C, Al-Badarin F, House JA, Kulkarni H, et al. The evolving landscape of Im- pella use in the United States among patients undergoing percutaneous coronary intervention with mechanical circulatory support. Circulation. 2020;141:273–284. doi: 10.1161/CIRCULATIONAHA.119.044007
43.          Dhruva SS, Ross JS, Mortazavi BJ, Hurley NC, Krumholz HM, Curtis JP, Berkowitz A, Masoudi FA, Messenger JC, Parzynski CS, et al. Associa- tion of use of an intravascular microaxial left ventricular assist device vs intra-aortic balloon pump with in-hospital mortality and major bleeding among patients with acute myocardial infarction complicated by cardio- genic shock. JAMA. 2020;323:734–745. doi: 10.1001/jama.2020.0254
44.          Esposito ML, Kapur NK. Acute mechanical circulatory support for cardio- genic shock: the “door to support” time. F1000Res. 2017;6:737. doi: 10.12688/f1000research.11150.1
45.          Mandawat A, Rao SV. Percutaneous mechanical circulatory support de- vices in cardiogenic shock. Circ Cardiovasc Interv. 2017;10:e004337. doi: 10.1161/CIRCINTERVENTIONS.116.004337
46.      Kapur NK, Alkhouli MA, DeMartini TJ, Faraz H, George ZH, Goodwin MJ, Hernandez-Montfort JA, Iyer VS, Josephy N, Kalra S, et al. Unloading the left ventricle before reperfusion in patients with anterior ST-segment- elevation myocardial infarction. Circulation. 2019;139:337–346. doi: 10.1161/CIRCULATIONAHA.118.038269
47.       O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, et al. 2013 ACCF/ AHA guideline for the management of ST-elevation myocardial infarc- tion: a report of the American College of Cardiology Foundation/Ameri- can Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362–e425.  doi:  10.1161/CIR.0b013e3182742cf6
48.        Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, et al; ESC Scientific Doc- ument Group. 2017 ESC guidelines for the management of acute myo- cardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiol- ogy (ESC). Eur Heart J. 2018;39:119–177. doi: 10.1093/eurheartj/ehx393
49.       Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, Webb JG, Steingart R, Picard MH, Menegus MA, et al; SHOCK Investigators, Should We Emergently Revascularize Occluded Coronaries for Cardio- genic Shock. One-year survival following early revascularization for car- diogenic shock. JAMA.  2001;285:190–192. doi: 10.1001/jama.285.2.190
50.      Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, Col J, White HD; SHOCK Investigators. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA.   2006;295:2511–2515.  doi:  10.1001/jama.295.21.2511
51.          Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P; AMIS Plus Registry Investigators. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med. 2008;149:618–626. doi: 10.7326/0003-4819-149-9-200811040-00005
52.          Kubo S, Yamaji K, Inohara T, Kohsaka S, Tanaka H, Ishii H, Uemura S, Amano T, Nakamura M, Kadota K. In-hospital outcomes after percutane- ous coronary intervention for acute coronary syndrome with cardiogenic shock (from a Japanese Nationwide Registry [J-PCI Registry]). Am J Car- diol.  2019;123:1595–1601.  doi:  10.1016/j.amjcard.2019.02.015
53.          Damluji AA, Bandeen-Roche K, Berkower C, Boyd CM, Al-Damluji MS, Cohen MG, Forman DE, Chaudhary R, Gerstenblith G, Walston JD, et al. Percutaneous coronary intervention in older patients with ST-segment el- evation myocardial infarction and cardiogenic shock. J Am Coll Cardiol. 2019;73:1890–1900. doi: 10.1016/j.jacc.2019.01.055
54.          Zeymer U, Hochadel M, Karcher A-K, Thiele H, Darius H, Behrens S, Schumacher B, Ince H, Hoffmeister H-M, Werner N, et al; ALKK Study Group. Procedural success rates and mortality in elderly patients with per- cutaneous coronary intervention for cardiogenic shock. JACC Cardiovas- cular interventions. 2019;12:1853–1859.
55.          Mehta RH, Lopes RD, Ballotta A, Frigiola A, Sketch MH Jr, Bossone E, Bates ER. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J.  2010;159:141–147.  doi:  10.1016/j.ahj.2009.10.035
56.          White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, Wong CK, Stewart JT, Aylward PE, Wong SC, et al. Comparison of per- cutaneous coronary intervention and coronary artery bypass grafting af- ter acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005;112:1992–2001. doi: 10.1161/CIRCULATIONAHA.105.540948
57.          Thiele H, Ohman EM, Desch S, Eitel I, de Waha S. Management of cardiogen- ic shock. Eur Heart J. 2015;36:1223–1230. doi: 10.1093/eurheartj/ehv051
58.          Sanborn TA, Sleeper LA, Webb JG, French JK, Bergman G, Parikh M, Wong SC, Boland J, Pfisterer M, Slater JN, et al; SHOCK Investigators. Correlates of one-year survival in patients with cardiogenic shock complicating acute myocardial infarction: angiographic findings from the SHOCK trial. J Am Coll Cardiol. 2003;42:1373–1379. doi: 10.1016/s0735-1097(03)01051-9
59.          Patel MR, Calhoon JH, Dehmer GJ, Grantham JA, Maddox TM, Maron DJ, Smith PK. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 appropriate use criteria for coronary revascularization in patients with acute coronary syndromes: a report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Asso- ciation, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Sur- geons.  J  Am  Coll  Cardiol.  2017;69:570–591.  doi:  10.1016/j.jacc.2016.10.034
60.          de Waha S, Jobs A, Eitel I, Pöss J, Stiermaier T, Meyer-Saraei R, Fuernau G, Zeymer U, Desch S, Thiele H. Multivessel versus culprit lesion only per- cutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care. 2018;7:28–37. doi: 10.1177/2048872617719640
61.          Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, et al; CULPRIT-SHOCK Inves- tigators. One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med. 2018;379:1699–1710. doi: 10.1056/NEJMoa1808788
62.          Lee JM, Rhee TM, Kim HK, Hwang D, Lee SH, Choi KH, Kim J, Park TK, Yang JH, Song YB, et al; KAMIR Investigators. Comparison of long-term clinical outcome between multivessel percutaneous coronary interven- tion versus infarct-related artery-only revascularization for patients with ST-segment-elevation myocardial infarction with cardiogenic shock. J Am Heart Assoc. 2019;8:e013870. doi: 10.1161/JAHA.119.013870
63.          Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, Campbell S, Storey RF, Gunn J. Incidence and predictors of stent thrombosis: a single- centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 2013;9:62–69. doi: 10.4244/EIJV9I1A10
64.          Orban M, Mayer K, Morath T, Bernlochner I, Hadamitzky M, Braun S, Schulz S, Hoppmann P, Hausleiter J, Tiroch K, et al. Prasugrel vs clopido- grel in cardiogenic shock patients undergoing primary PCI for acute myo- cardial infarction: results of the ISAR-SHOCK registry. Thromb Haemost. 2014;112:1190–1197.  doi:  10.1160/TH14-06-0489
65.          Orban M, Limbourg T, Neumann FJ, Ferenc M, Olbrich HG, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, et al. ADP receptor an- tagonists in patients with acute myocardial infarction complicated by car- diogenic shock: a post hoc IABP-SHOCK II trial subgroup analysis. EuroIn- tervention.  2016;12:e1395–e1403. doi: 10.4244/EIJY15M12_04
66.          Parodi G, Xanthopoulou I, Bellandi B, Gkizas V, Valenti R, Karanikas S, Migliorini A, Angelidis C, Abbate R, Patsilinakos S, et al. Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study. J Am Coll Cardiol. 2015;65:511–512. doi: 10.1016/j.jacc.2014.08.056
67.          Alexopoulos D, Pappas C, Sfantou D, Xanthopoulou I, Didagelos M, Kikas P, Ziakas A, Tziakas D, Karvounis H, Iliodromitis E. Cangrelor in ticagrelor-load- ed STEMI patients undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2018;72:1750–1751. doi: 10.1016/j.jacc.2018.07.041
68.          Franchi F, Rollini F, Rivas A, Wali M, Briceno M, Agarwal M, Shaikh Z, Nawaz A, Silva G, Been L, et al. Platelet inhibition with cangrelor and crushed ticagrelor in patients with ST-segment-elevation myocardial infarc- tion undergoing primary percutaneous coronary intervention. Circulation. 2019;139:1661–1670.   doi:   10.1161/CIRCULATIONAHA.118.038317
69.          Marian MJ, Abu Daya H, Chatterjee A, Al Solaiman F, Sasse MF, Fonbah WS, Workman RW, Johnson BE, Carlson SE, Brott BC, et al. Effects of crushed ticagrelor versus eptifibatide bolus plus clopidogrel in troponin- negative acute coronary syndrome patients undergoing percutaneous coronary intervention: a randomized clinical trial. J Am Heart Assoc. 2019;8:e012844. doi: 10.1161/JAHA.119.012844
70.          Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypo- thermia to improve the neurologic outcome after cardiac arrest. N Engl J Med.  2002;346:549–556.  doi:  10.1056/NEJMoa012689
71.          Bernard SA, Gray TW, Buist MD, Jones BM, Silvester W, Gutteridge G, Smith K. Treatment of comatose survivors of out-of-hospital cardiac ar- rest with induced hypothermia. N Engl J Med. 2002;346:557–563. doi: 10.1056/NEJMoa003289
72.          Nielsen N, Wetterslev J, Cronberg T, Erlinge D, Gasche Y, Hassager C, Horn J, Hovdenes J, Kjaergaard J, Kuiper M, et al; TTM Trial Investigators. Tar- geted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013;369:2197–2206. doi: 10.1056/NEJMoa1310519
73.          Rab T, Kern KB, Tamis-Holland JE, Henry TD, McDaniel M, Dickert NW, Cigarroa JE, Keadey M, Ramee S; Interventional Council, American Col- lege of Cardiology. Cardiac arrest: a treatment algorithm for emergent invasive cardiac procedures in the resuscitated comatose patient. J Am Coll  Cardiol.  2015;66:62–73. doi: 10.1016/j.jacc.2015.05.009
74.          Lotfi A, Klein LW, Hira RS, Mallidi J, Mehran R, Messenger JC, Pinto DS, Mooney MR, Rab T, Yannopoulos D, et al. SCAI expert consensus statement on out of hospital cardiac arrest. Catheter Cardiovasc Interv. 2020;96:844–861.  doi:  10.1002/ccd.28990
75.          Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, et al. Coro- nary angiography after cardiac arrest without ST-segment elevation. N Engl J Med. 2019;380:1397–1407. doi: 10.1056/NEJMoa1816897
76.          Bartos JA, Carlson K, Carlson C, Raveendran G, John R, Aufderheide TP, Yannopoulos D. Surviving refractory out-of-hospital ventricular fi- brillation cardiac arrest: critical care and extracorporeal membrane oxygenation management. Resuscitation. 2018;132:47–55. doi: 10.1016/j.resuscitation.2018.08.030
77.          Yannopoulos D, Bartos JA, Raveendran G, Conterato M, Frascone RJ, Trembley A, John R, Connett J, Benditt DG, Lurie KG, et al. Coronary artery disease in patients with out-of-hospital refractory ventricular fi- brillation cardiac arrest. J Am Coll Cardiol. 2017;70:1109–1117. doi: 10.1016/j.jacc.2017.06.059
78.        Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavík V, Hochman JS. A severity scoring system for risk assessment of patients with cardio- genic shock: a report from the SHOCK trial and registry. Am Heart J. 2010;160:443–450.   doi:   10.1016/j.ahj.2010.06.024
79.        Pöss J, Köster J, Fuernau G, Eitel I, de Waha S, Ouarrak T, Lassus J, Harjola VP, Zeymer U, Thiele H, et al. Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017;69:1913– 1920.  doi:  10.1016/j.jacc.2017.02.027
80.        Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, Hodgson C, Scheinkestel C, Cooper DJ, Thiagarajan RR, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)- score. Eur Heart J. 2015;36:2246–2256. doi: 10.1093/eurheartj/ehv194
81.       Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, et al. Shock team ap- proach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept. Circulation. 2019;140:98–100. doi:  10.1161/CIRCULATIONAHA.119.040654

 

[PDF] [Зміст журналу]